Cardiovascular abnormalities in obstructive cholestasis: the possible mechanisms

Area of Science:

• Cardiovascular Physiology
• Hepatology
• Cellular Signaling

Background:

• Cholestatic liver disease presents with significant cardiovascular complications, including bradycardia, hypotension, QT prolongation, and vasodilation.
• Patients with cholestasis exhibit increased vulnerability to postoperative renal failure and hemorrhagic shock.

Purpose of the Study:

• To review recent in vivo and in vitro findings on the pathogenic mechanisms of cardiac and vascular abnormalities in obstructive cholestasis.
• To highlight areas of agreement and controversy in the current research.

Main Methods:

• Review of recent scientific literature.
• Analysis of in vivo and in vitro experimental findings.

Main Results:

• Cardiovascular dysfunction in cholestasis is predominantly linked to bile acids.
• Increased nitric oxide, endogenous opioids, and endocannabinoids are identified as key contributing factors.
• These mediators interact to induce vasodilation and impair sympathetic cardiovascular responses.

Conclusions:

• Bile acids are primary drivers of cardiovascular abnormalities in obstructive cholestasis.
• The interplay of nitric oxide, opioids, and endocannabinoids significantly contributes to vascular and cardiac dysfunction.
• Understanding these mechanisms is crucial for managing cholestatic liver disease complications.